Known hypersensitivity to Linezolid or any other drug component. Linezolid shouldn't be used in patients receiving any medicinal products inhibiting monoamine oxidases A or B (e.g., Phenelzine, Isocarboxazid, Selegiline, Moclobemid) or within two weeks after administration of such drugs.
Except cases when there is a possibility of close monitoring of blood pressure, Linezolid should not be prescribed in patients with the following concomitant clinical conditions or concurrent administration of such drugs: non-controlled arterial hypertension, pheochromocytoma, carcinoid, thyrotoxicosis, bipolar depression, schizoaffective disorder, acute episodes of dizziness; serotonin reuptake inhibitors, tricyclic antidepressants, serotonin 5-HT1 receptor agonists (triptanes), directly and indirectly acting sympathomimetics (including adrenergic bronchodilators, pseudoephedrine, phenylpropanolamine), vasopressors (epinephrine, norepinephrine), dopaminergic compounds (dopamine, dobutamine), pethidine or buspirone.